Search Results for “” – Page 13 – OSLM

OSLM

Outcome Studies
in Laboratory Medicine

guest

👤

Learn more about this platform

Categories:Clinical outcomes Observational

265 Publications found

Time in blood glucose range 70 to 180 mg/dL and survival rate in critically ill patients: A retrospective cohort study.

b

PloS one

January 1, 2021

p Diabetes

c Change patient management Clinical outcomes Observational
Osimertinib for patients with poor performance status and EGFR T790M mutation-positive advanced non-small cell lung cancer: a phase II clinical trial.

b

Investigational new drugs

December 1, 2020

p Cancer

c Change patient management Clinical outcomes Observational
Biomarkers of Osimertinib Response in Patients with Refractory, EGFR-T790M-positive Non-Small Cell Lung Cancer and Central Nervous System Metastases: The APOLLO Study.

b

Clinical cancer research : an official journal of the American Association for Cancer Research

December 1, 2020

p Cancer

c Change patient management Clinical outcomes Observational
Clinical Impact of Plasma and Tissue Next-Generation Sequencing in Advanced Non-Small Cell Lung Cancer: A Real-World Experience.

b

The oncologist

December 1, 2020

p Cancer

c Change patient management Clinical outcomes Observational
Site-Specific and Targeted Therapy Based on Molecular Profiling by Next-Generation Sequencing for Cancer of Unknown Primary Site: A Nonrandomized Phase 2 Clinical Trial.

b

JAMA oncology

December 1, 2020

p Cancer

c Change patient management Clinical outcomes Observational
Biomarker-driven therapies for previously treated squamous non-small-cell lung cancer (Lung-MAP SWOG S1400): a biomarker-driven master protocol.

b

The Lancet. Oncology

December 1, 2020

p Cancer

c Change patient management Clinical outcomes Highlighted Observational
C-reactive protein- and clinical symptoms-guided strategy in term neonates with early-onset sepsis reduced antibiotic use and hospital stay: a quality improvement initiative.

b

BMC pediatrics

November 20, 2020

p Antibiotic Guidance

c Change patient management Clinical outcomes Observational Operational efficiencies
Relevance and Effectiveness of Molecular Tumor Board Recommendations for Patients With Non-Small-Cell Lung Cancer With Rare or Complex Mutational Profiles.

b

JCO precision oncology

November 1, 2020

p Cancer

c Change patient management Clinical outcomes Observational
Impact of the implementation of new guidelines on the management of patients with HIV infection at an advanced HIV clinic in Kinshasa, Democratic Republic of Congo (DRC).

b

BMC infectious diseases

October 7, 2020

p HIV POCT

c Change patient management Clinical outcomes Observational
Real-world data from a molecular tumor board demonstrates improved outcomes with a precision N-of-One strategy.

b

Nature communications

October 2, 2020

p Cancer

c Change patient management Clinical outcomes Highlighted Observational